{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:33:51Z","timestamp":1794378831173,"version":"4.9.0"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03616-3","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T02:20:03Z","timestamp":1753669203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Nanoparticles induced cuproptosis to enhance antitumor immunotherapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Wen","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhuo","family":"Ba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"3616_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.biomaterials.2017.09.017","volume":"148","author":"W Song","year":"2017","unstructured":"Song W, Musetti SN, Huang L. Nanomaterials for cancer immunotherapy. Biomaterials. 2017;148:16\u201330. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.09.017.","journal-title":"Biomaterials"},{"issue":"7","key":"3616_CR2","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1200\/jco.2005.04.9676","volume":"24","author":"AM Brade","year":"2006","unstructured":"Brade AM, Tannock IF. Scheduling of radiation and chemotherapy for limited-stage small-cell lung cancer: repopulation as a cause of treatment failure? J Clin Oncol. 2006;24(7):1020\u20132. https:\/\/doi.org\/10.1200\/jco.2005.04.9676.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3616_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.trecan.2021.10.003","volume":"8","author":"KB Pointer","year":"2022","unstructured":"Pointer KB, Pitroda SP, Weichselbaum RR. Radiotherapy and immunotherapy: open questions and future strategies. Trends Cancer. 2022;8(1):9\u201320. https:\/\/doi.org\/10.1016\/j.trecan.2021.10.003.","journal-title":"Trends Cancer"},{"issue":"6586","key":"3616_CR4","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254\u201361. https:\/\/doi.org\/10.1126\/science.abf0529.","journal-title":"Science"},{"issue":"22","key":"3616_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202212267","volume":"35","author":"B Guo","year":"2023","unstructured":"Guo B, et al. Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with \u03b1PD-L1 for enhanced cancer immunotherapy. Adv Mater. 2023;35(22): e2212267. https:\/\/doi.org\/10.1002\/adma.202212267.","journal-title":"Adv Mater"},{"issue":"1","key":"3616_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15(1):174. https:\/\/doi.org\/10.1186\/s13045-022-01392-3.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"3616_CR7","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/med.22025","volume":"44","author":"J Wu","year":"2024","unstructured":"Wu J, et al. Cuproptosis: mechanism, role, and advances in urological malignancies. Med Res Rev. 2024;44(4):1662\u201382. https:\/\/doi.org\/10.1002\/med.22025.","journal-title":"Med Res Rev"},{"issue":"29","key":"3616_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202301346","volume":"12","author":"F Zhao","year":"2023","unstructured":"Zhao F, et al. Redox homeostasis disruptors based on metal-phenolic network nanoparticles for chemo\/chemodynamic synergistic tumor therapy through activating apoptosis and cuproptosis. Adv Healthc Mater. 2023;12(29): e2301346. https:\/\/doi.org\/10.1002\/adhm.202301346.","journal-title":"Adv Healthc Mater"},{"issue":"7","key":"3616_CR9","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1021\/acs.nanolett.3c00434","volume":"23","author":"K Chen","year":"2023","unstructured":"Chen K, Zhou A, Zhou X, Liu Y, Xu Y, Ning X. An intelligent cell-derived nanorobot bridges synergistic crosstalk between sonodynamic therapy and cuproptosis to promote cancer treatment. Nano Lett. 2023;23(7):3038\u201347. https:\/\/doi.org\/10.1021\/acs.nanolett.3c00434.","journal-title":"Nano Lett"},{"issue":"43","key":"3616_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202204733","volume":"34","author":"Y Xu","year":"2022","unstructured":"Xu Y, et al. An enzyme-engineered nonporous copper(I) coordination polymer nanoplatform for cuproptosis-based synergistic cancer therapy. Adv Mater. 2022;34(43): e2204733. https:\/\/doi.org\/10.1002\/adma.202204733.","journal-title":"Adv Mater"},{"issue":"1","key":"3616_CR11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7(1):378. https:\/\/doi.org\/10.1038\/s41392-022-01229-y.","journal-title":"Signal Transduct Target Ther"},{"key":"3616_CR12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jconrel.2023.08.055","volume":"362","author":"T Liu","year":"2023","unstructured":"Liu T, et al. Cuproptosis-immunotherapy using PD-1 overexpressing T cell membrane-coated nanosheets efficiently treats tumor. J Control Release. 2023;362:502\u201312. https:\/\/doi.org\/10.1016\/j.jconrel.2023.08.055.","journal-title":"J Control Release"},{"issue":"11","key":"3616_CR13","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1039\/d2sc06601g","volume":"14","author":"L Pang","year":"2023","unstructured":"Pang L, et al. Smart down\/upconversion nanomachines integrated with \u201cAND\u201d logic computation and enzyme-free amplification for NIR-II fluorescence-assisted precise and enhanced photodynamic therapy. Chem Sci. 2023;14(11):3070\u20135. https:\/\/doi.org\/10.1039\/d2sc06601g.","journal-title":"Chem Sci"},{"issue":"7","key":"3616_CR14","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1021\/acs.analchem.2c05333","volume":"95","author":"S Hu","year":"2023","unstructured":"Hu S, Huang L, Zhou L, Wu T, Zhao S, Zhang L. Single-excitation triple-emission down-\/up-conversion nanoassemblies for tumor microenvironment-enhanced ratiometric NIR-II fluorescence imaging and chemo-\/photodynamic combination therapy. Anal Chem. 2023;95(7):3830\u20139. https:\/\/doi.org\/10.1021\/acs.analchem.2c05333.","journal-title":"Anal Chem"},{"issue":"50","key":"3616_CR15","doi-asserted-by":"publisher","first-page":"17645","DOI":"10.1021\/acs.analchem.2c04392","volume":"94","author":"M Ye","year":"2022","unstructured":"Ye M, Hu S, Zhou L, Tang X, Zhao S, Zhao J. fluidic membrane accelerating the kinetics of photoactivatable hybridization chain reaction for accurate imaging of tumor-derived exosomes. Anal Chem. 2022;94(50):17645\u201352. https:\/\/doi.org\/10.1021\/acs.analchem.2c04392.","journal-title":"Anal Chem"},{"issue":"2","key":"3616_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","volume":"22","author":"EJ Ge","year":"2022","unstructured":"Ge EJ, et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer. 2022;22(2):102\u201313. https:\/\/doi.org\/10.1038\/s41568-021-00417-2.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"3616_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118893","volume":"1868","author":"VC Shanbhag","year":"2021","unstructured":"Shanbhag VC, Gudekar N, Jasmer K, Papageorgiou C, Singh K, Petris MJ. Copper metabolism as a unique vulnerability in cancer. Biochim Biophys Acta Mol Cell Res. 2021;1868(2): 118893. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118893.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3616_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jconrel.2021.11.041","volume":"341","author":"M Chen","year":"2022","unstructured":"Chen M, et al. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy. J Contr Releas. 2022;341:351\u201363. https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.041.","journal-title":"J Contr Releas"},{"issue":"10","key":"3616_CR19","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1039\/d1dt03749h","volume":"51","author":"YT Chen","year":"2022","unstructured":"Chen YT, Zhang SN, Wang ZF, Wei QM, Zhang SH. Discovery of thirteen cobalt(II) and copper(II) salicylaldehyde Schiff base complexes that induce apoptosis and autophagy in human lung adenocarcinoma A549\/DDP cells and that can overcome cisplatin resistance in vitro and in vivo. Dalton Trans. 2022;51(10):4068\u201378. https:\/\/doi.org\/10.1039\/d1dt03749h.","journal-title":"Dalton Trans"},{"issue":"7","key":"3616_CR20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2174\/156800905774574066","volume":"5","author":"VL Goodman","year":"2005","unstructured":"Goodman VL, Brewer GJ, Merajver SD. Control of copper status for cancer therapy. Curr Cancer Drug Targets. 2005;5(7):543\u20139. https:\/\/doi.org\/10.2174\/156800905774574066.","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"3616_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1440-1681.2008.04969.x","volume":"36","author":"L Finney","year":"2009","unstructured":"Finney L, Vogt S, Fukai T, Glesne D. Copper and angiogenesis: unravelling a relationship key to cancer progression. Clin Exp Pharmacol Physiol. 2009;36(1):88\u201394. https:\/\/doi.org\/10.1111\/j.1440-1681.2008.04969.x.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"3616_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1677\/erc.0.0110255","volume":"11","author":"VL Goodman","year":"2004","unstructured":"Goodman VL, Brewer GJ, Merajver SD. Copper deficiency as an anti-cancer strategy. Endocr Relat Cancer. 2004;11(2):255\u201363. https:\/\/doi.org\/10.1677\/erc.0.0110255.","journal-title":"Endocr Relat Cancer"},{"issue":"21","key":"3616_CR23","doi-asserted-by":"publisher","first-page":"13786","DOI":"10.1074\/jbc.272.21.13786","volume":"272","author":"E Georgatsou","year":"1997","unstructured":"Georgatsou E, Mavrogiannis LA, Fragiadakis GS, Alexandraki D. The yeast Fre1p\/Fre2p cupric reductases facilitate copper uptake and are regulated by the copper-modulated Mac1p activator. J Biol Chem. 1997;272(21):13786\u201392. https:\/\/doi.org\/10.1074\/jbc.272.21.13786.","journal-title":"J Biol Chem"},{"issue":"9","key":"3616_CR24","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1073\/pnas.89.9.3869","volume":"89","author":"A Dancis","year":"1992","unstructured":"Dancis A, Roman DG, Anderson GJ, Hinnebusch AG, Klausner RD. Ferric reductase of Saccharomyces cerevisiae: molecular characterization, role in iron uptake, and transcriptional control by iron. Proc Natl Acad Sci U S A. 1992;89(9):3869\u201373. https:\/\/doi.org\/10.1073\/pnas.89.9.3869.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3616_CR25","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1182\/blood-2006-02-003681","volume":"108","author":"RS Ohgami","year":"2006","unstructured":"Ohgami RS, Campagna DR, McDonald A, Fleming MD. The Steap proteins are metalloreductases. Blood. 2006;108(4):1388\u201394. https:\/\/doi.org\/10.1182\/blood-2006-02-003681.","journal-title":"Blood"},{"key":"3616_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103558","volume":"71","author":"G Wu","year":"2021","unstructured":"Wu G, et al. ZNF711 down-regulation promotes CISPLATIN resistance in epithelial ovarian cancer via interacting with JHDM2A and suppressing SLC31A1 expression. EBioMedicine. 2021;71: 103558. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103558.","journal-title":"EBioMedicine"},{"issue":"2","key":"3616_CR27","doi-asserted-by":"publisher","first-page":"C235","DOI":"10.1152\/ajpcell.00106.2018","volume":"316","author":"A Barca","year":"2019","unstructured":"Barca A, et al. Carnosine modulates the Sp1-Slc31a1\/Ctr1 copper-sensing system and influences copper homeostasis in murine CNS-derived cells. Am J Physiol Cell Physiol. 2019;316(2):C235-c245. https:\/\/doi.org\/10.1152\/ajpcell.00106.2018.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3616_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.phymed.2018.04.058","volume":"48","author":"W Zhang","year":"2018","unstructured":"Zhang W, et al. Curcumin enhances cisplatin sensitivity of human NSCLC cell lines through influencing Cu-Sp1-CTR1 regulatory loop. Phytomedicine. 2018;48:51\u201361. https:\/\/doi.org\/10.1016\/j.phymed.2018.04.058.","journal-title":"Phytomedicine"},{"issue":"3","key":"3616_CR29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1124\/mol.108.046771","volume":"74","author":"IS Song","year":"2008","unstructured":"Song IS, et al. Transcription factor Sp1 plays an important role in the regulation of copper homeostasis in mammalian cells. Mol Pharmacol. 2008;74(3):705\u201313. https:\/\/doi.org\/10.1124\/mol.108.046771.","journal-title":"Mol Pharmacol"},{"issue":"9","key":"3616_CR30","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1111\/jcmm.15183","volume":"24","author":"C Cheng","year":"2020","unstructured":"Cheng C, et al. PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1. J Cell Mol Med. 2020;24(9):5274\u201389. https:\/\/doi.org\/10.1111\/jcmm.15183.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"3616_CR31","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1039\/c5mt00131e","volume":"7","author":"CY Tsai","year":"2015","unstructured":"Tsai CY, Liebig JK, Tsigelny IF, Howell SB. The copper transporter 1 (CTR1) is required to maintain the stability of copper transporter 2 (CTR2). Metallomics. 2015;7(11):1477\u201387. https:\/\/doi.org\/10.1039\/c5mt00131e.","journal-title":"Metallomics"},{"issue":"3","key":"3616_CR32","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1152\/physrev.00004.2006","volume":"87","author":"S Lutsenko","year":"2007","unstructured":"Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY. Function and regulation of human copper-transporting ATPases. Physiol Rev. 2007;87(3):1011\u201346. https:\/\/doi.org\/10.1152\/physrev.00004.2006.","journal-title":"Physiol Rev"},{"issue":"18","key":"3616_CR33","doi-asserted-by":"publisher","first-page":"5918","DOI":"10.1128\/jb.173.18.5918-5920.1991","volume":"173","author":"EB Gralla","year":"1991","unstructured":"Gralla EB, Valentine JS. Null mutants of Saccharomyces cerevisiae Cu,Zn superoxide dismutase: characterization and spontaneous mutation rates. J Bacteriol. 1991;173(18):5918\u201320. https:\/\/doi.org\/10.1128\/jb.173.18.5918-5920.1991.","journal-title":"J Bacteriol"},{"issue":"3","key":"3616_CR34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/sj.onc.1208207","volume":"24","author":"S Elchuri","year":"2005","unstructured":"Elchuri S, et al. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene. 2005;24(3):367\u201380. https:\/\/doi.org\/10.1038\/sj.onc.1208207.","journal-title":"Oncogene"},{"issue":"1","key":"3616_CR35","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1038\/s41467-022-31413-1","volume":"13","author":"E N\u00fdvltov\u00e1","year":"2022","unstructured":"N\u00fdvltov\u00e1 E, Dietz JV, Seravalli J, Khalimonchuk O, Barrientos A. Coordination of metal center biogenesis in human cytochrome c oxidase. Nat Commun. 2022;13(1):3615. https:\/\/doi.org\/10.1038\/s41467-022-31413-1.","journal-title":"Nat Commun"},{"issue":"3","key":"3616_CR36","doi-asserted-by":"publisher","first-page":"826s","DOI":"10.1093\/ajcn\/88.3.826S","volume":"88","author":"JR Prohaska","year":"2008","unstructured":"Prohaska JR. Role of copper transporters in copper homeostasis. Am J Clin Nutr. 2008;88(3):826s-s829. https:\/\/doi.org\/10.1093\/ajcn\/88.3.826S.","journal-title":"Am J Clin Nutr"},{"issue":"34","key":"3616_CR37","doi-asserted-by":"publisher","first-page":"35334","DOI":"10.1074\/jbc.M404747200","volume":"279","author":"YC Horng","year":"2004","unstructured":"Horng YC, Cobine PA, Maxfield AB, Carr HS, Winge DR. Specific copper transfer from the Cox17 metallochaperone to both Sco1 and Cox11 in the assembly of yeast cytochrome c oxidase. J Biol Chem. 2004;279(34):35334\u201340. https:\/\/doi.org\/10.1074\/jbc.M404747200.","journal-title":"J Biol Chem"},{"issue":"7","key":"3616_CR38","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.bbamcr.2006.03.002","volume":"1763","author":"PA Cobine","year":"2006","unstructured":"Cobine PA, Pierrel F, Winge DR. Copper trafficking to the mitochondrion and assembly of copper metalloenzymes. Biochim Biophys Acta. 2006;1763(7):759\u201372. https:\/\/doi.org\/10.1016\/j.bbamcr.2006.03.002.","journal-title":"Biochim Biophys Acta"},{"issue":"19","key":"3616_CR39","doi-asserted-by":"publisher","first-page":"6803","DOI":"10.1073\/pnas.0800019105","volume":"105","author":"L Banci","year":"2008","unstructured":"Banci L, Bertini I, Ciofi-Baffoni S, Hadjiloi T, Martinelli M, Palumaa P. Mitochondrial copper(I) transfer from Cox17 to Sco1 is coupled to electron transfer. Proc Natl Acad Sci U S A. 2008;105(19):6803\u20138. https:\/\/doi.org\/10.1073\/pnas.0800019105.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"3616_CR40","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/hmg\/ddh197","volume":"13","author":"SC Leary","year":"2004","unstructured":"Leary SC, et al. Human SCO1 and SCO2 have independent, cooperative functions in copper delivery to cytochrome c oxidase. Hum Mol Genet. 2004;13(17):1839\u201348. https:\/\/doi.org\/10.1093\/hmg\/ddh197.","journal-title":"Hum Mol Genet"},{"issue":"21","key":"3616_CR41","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.1128\/mcb.22.21.7614-7621.2002","volume":"22","author":"Y Takahashi","year":"2002","unstructured":"Takahashi Y, et al. Mammalian copper chaperone Cox17p has an essential role in activation of cytochrome C oxidase and embryonic development. Mol Cell Biol. 2002;22(21):7614\u201321. https:\/\/doi.org\/10.1128\/mcb.22.21.7614-7621.2002.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"3616_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.abb.2007.04.021","volume":"463","author":"S La Fontaine","year":"2007","unstructured":"La Fontaine S, Mercer JF. Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. Arch Biochem Biophys. 2007;463(2):149\u201367. https:\/\/doi.org\/10.1016\/j.abb.2007.04.021.","journal-title":"Arch Biochem Biophys"},{"issue":"35","key":"3616_CR43","doi-asserted-by":"publisher","first-page":"27111","DOI":"10.1074\/jbc.M110.154468","volume":"285","author":"WCJ Singleton","year":"2010","unstructured":"Singleton WCJ, et al. Role of glutaredoxin1 and glutathione in regulating the activity of the copper-transporting P-type ATPases, ATP7A and ATP7B. J Biol Chem. 2010;285(35):27111\u201321. https:\/\/doi.org\/10.1074\/jbc.M110.154468.","journal-title":"J Biol Chem"},{"issue":"5 Suppl 1","key":"3616_CR44","doi-asserted-by":"publisher","first-page":"1527s","DOI":"10.1093\/jn\/133.5.1527S","volume":"133","author":"H Shim","year":"2003","unstructured":"Shim H, Harris ZL. Genetic defects in copper metabolism. J Nutr. 2003;133(5 Suppl 1):1527s-s1531. https:\/\/doi.org\/10.1093\/jn\/133.5.1527S.","journal-title":"J Nutr"},{"issue":"20","key":"3616_CR45","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1158\/0008-5472.Can-13-3527","volume":"74","author":"R Safi","year":"2014","unstructured":"Safi R, et al. Copper signaling axis as a target for prostate cancer therapeutics. Cancer Res. 2014;74(20):5819\u201331. https:\/\/doi.org\/10.1158\/0008-5472.Can-13-3527.","journal-title":"Cancer Res"},{"issue":"2","key":"3616_CR46","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1039\/c6mt00202a","volume":"9","author":"S Blockhuys","year":"2017","unstructured":"Blockhuys S, et al. Defining the human copper proteome and analysis of its expression variation in cancers. Metallomics. 2017;9(2):112\u201323. https:\/\/doi.org\/10.1039\/c6mt00202a.","journal-title":"Metallomics"},{"issue":"3","key":"3616_CR47","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12282-019-01044-4","volume":"27","author":"S Blockhuys","year":"2020","unstructured":"Blockhuys S, Brady DC, Wittung-Stafshede P. Evaluation of copper chaperone ATOX1 as prognostic biomarker in breast cancer. Breast Cancer. 2020;27(3):505\u20139. https:\/\/doi.org\/10.1007\/s12282-019-01044-4.","journal-title":"Breast Cancer"},{"issue":"6","key":"3616_CR48","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3109\/10408363.2015.1050714","volume":"52","author":"R Pannecoeck","year":"2015","unstructured":"Pannecoeck R, et al. Vascular adhesion protein-1: role in human pathology and application as a biomarker. Crit Rev Clin Lab Sci. 2015;52(6):284\u2013300. https:\/\/doi.org\/10.3109\/10408363.2015.1050714.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"3616_CR49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2018.01.006","volume":"417","author":"KA Johnston","year":"2018","unstructured":"Johnston KA, Lopez KM. Lysyl oxidase in cancer inhibition and metastasis. Cancer Lett. 2018;417:174\u201381. https:\/\/doi.org\/10.1016\/j.canlet.2018.01.006.","journal-title":"Cancer Lett"},{"issue":"21","key":"3616_CR50","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1158\/0008-5472.Can-16-3152","volume":"77","author":"F Salvador","year":"2017","unstructured":"Salvador F, et al. Lysyl oxidase-like protein LOXL2 promotes lung metastasis of breast cancer. Cancer Res. 2017;77(21):5846\u201359. https:\/\/doi.org\/10.1158\/0008-5472.Can-16-3152.","journal-title":"Cancer Res"},{"issue":"5","key":"3616_CR51","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1002\/hep.27320","volume":"60","author":"CC Wong","year":"2014","unstructured":"Wong CC, et al. Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma. Hepatology. 2014;60(5):1645\u201358. https:\/\/doi.org\/10.1002\/hep.27320.","journal-title":"Hepatology"},{"issue":"14","key":"3616_CR52","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1038\/onc.2012.202","volume":"32","author":"AM Baker","year":"2013","unstructured":"Baker AM, Bird D, Lang G, Cox TR, Erler JT. Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK. Oncogene. 2013;32(14):1863\u20138. https:\/\/doi.org\/10.1038\/onc.2012.202.","journal-title":"Oncogene"},{"issue":"1","key":"3616_CR53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3164\/jcbn.22-9","volume":"71","author":"T Kamiya","year":"2022","unstructured":"Kamiya T. Copper in the tumor microenvironment and tumor metastasis. J Clin Biochem Nutr. 2022;71(1):22\u20138. https:\/\/doi.org\/10.3164\/jcbn.22-9.","journal-title":"J Clin Biochem Nutr"},{"issue":"7","key":"3616_CR54","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1158\/1078-0432.Ccr-14-1959","volume":"21","author":"BR O'Leary","year":"2015","unstructured":"O\u2019Leary BR, et al. Loss of SOD3 (EcSOD) expression promotes an aggressive phenotype in human pancreatic ductal adenocarcinoma. Clin Cancer Res. 2015;21(7):1741\u201351. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-14-1959.","journal-title":"Clin Cancer Res"},{"key":"3616_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3612589","volume":"2016","author":"MO Laukkanen","year":"2016","unstructured":"Laukkanen MO. Extracellular superoxide dismutase: growth promoter or tumor suppressor? Oxid Med Cell Longev. 2016;2016: 3612589. https:\/\/doi.org\/10.1155\/2016\/3612589.","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"3616_CR56","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1073\/pnas.1910722117","volume":"117","author":"S Blockhuys","year":"2020","unstructured":"Blockhuys S, Zhang X, Wittung-Stafshede P. Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration. Proc Natl Acad Sci U S A. 2020;117(4):2014\u20139. https:\/\/doi.org\/10.1073\/pnas.1910722117.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"3616_CR57","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1158\/1078-0432.Ccr-06-0171","volume":"12","author":"JC Juarez","year":"2006","unstructured":"Juarez JC, et al. Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1. Clin Cancer Res. 2006;12(16):4974\u201382. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-0171.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3616_CR58","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1038\/s41467-021-23408-1","volume":"12","author":"D Ash","year":"2021","unstructured":"Ash D, et al. The P-type ATPase transporter ATP7A promotes angiogenesis by limiting autophagic degradation of VEGFR2. Nat Commun. 2021;12(1):3091. https:\/\/doi.org\/10.1038\/s41467-021-23408-1.","journal-title":"Nat Commun"},{"key":"3616_CR59","doi-asserted-by":"publisher","DOI":"10.1515\/9783110470734-022","author":"D Denoyer","year":"2018","unstructured":"Denoyer D, Clatworthy SAS, Cater MA. Copper complexes in cancer therapy. Met Ions Life Sci. 2018. https:\/\/doi.org\/10.1515\/9783110470734-022.","journal-title":"Met Ions Life Sci"},{"issue":"30","key":"3616_CR60","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.2174\/092986708786848479","volume":"15","author":"T Furukawa","year":"2008","unstructured":"Furukawa T, Komatsu M, Ikeda R, Tsujikawa K, Akiyama S. Copper transport systems are involved in multidrug resistance and drug transport. Curr Med Chem. 2008;15(30):3268\u201378. https:\/\/doi.org\/10.2174\/092986708786848479.","journal-title":"Curr Med Chem"},{"issue":"3","key":"3616_CR61","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/iub.1722","volume":"70","author":"YQ Li","year":"2018","unstructured":"Li YQ, Yin JY, Liu ZQ, Li XP. Copper efflux transporters ATP7A and ATP7B: novel biomarkers for platinum drug resistance and targets for therapy. IUBMB Life. 2018;70(3):183\u201391. https:\/\/doi.org\/10.1002\/iub.1722.","journal-title":"IUBMB Life"},{"key":"3616_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ph14060549","author":"MT Kuo","year":"2021","unstructured":"Kuo MT, Huang YF, Chou CY, Chen HHW. Targeting the copper transport system to improve treatment efficacies of platinum-containing drugs in cancer chemotherapy. Pharmaceuticals (Basel). 2021. https:\/\/doi.org\/10.3390\/ph14060549.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"3616_CR63","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/ana.20047","volume":"55","author":"CT Sheline","year":"2004","unstructured":"Sheline CT, Choi DW. Cu2+ toxicity inhibition of mitochondrial dehydrogenases in vitro and in vivo. Ann Neurol. 2004;55(5):645\u201353. https:\/\/doi.org\/10.1002\/ana.20047.","journal-title":"Ann Neurol"},{"issue":"2","key":"3616_CR64","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.bbrc.2004.12.022","volume":"327","author":"M Arciello","year":"2005","unstructured":"Arciello M, Rotilio G, Rossi L. Copper-dependent toxicity in SH-SY5Y neuroblastoma cells involves mitochondrial damage. Biochem Biophys Res Commun. 2005;327(2):454\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2004.12.022.","journal-title":"Biochem Biophys Res Commun"},{"key":"3616_CR65","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbpa.2017.11.003","volume":"42","author":"EA Rowland","year":"2018","unstructured":"Rowland EA, Snowden CK, Cristea IM. Protein lipoylation: an evolutionarily conserved metabolic regulator of health and disease. Curr Opin Chem Biol. 2018;42:76\u201385. https:\/\/doi.org\/10.1016\/j.cbpa.2017.11.003.","journal-title":"Curr Opin Chem Biol"},{"issue":"2","key":"3616_CR66","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1021\/jacs.6b09567","volume":"139","author":"D Brancaccio","year":"2017","unstructured":"Brancaccio D, Gallo A, Piccioli M, Novellino E, Ciofi-Baffoni S, Banci L. [4Fe-4S] cluster assembly in mitochondria and its impairment by copper. J Am Chem Soc. 2017;139(2):719\u201330. https:\/\/doi.org\/10.1021\/jacs.6b09567.","journal-title":"J Am Chem Soc"},{"issue":"2","key":"3616_CR67","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41589-022-01159-4","volume":"19","author":"V Schulz","year":"2023","unstructured":"Schulz V, et al. Functional spectrum and specificity of mitochondrial ferredoxins FDX1 and FDX2. Nat Chem Biol. 2023;19(2):206\u201317. https:\/\/doi.org\/10.1038\/s41589-022-01159-4.","journal-title":"Nat Chem Biol"},{"issue":"2","key":"3616_CR68","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.bbamcr.2011.11.002","volume":"1823","author":"Y Shi","year":"2012","unstructured":"Shi Y, Ghosh M, Kovtunovych G, Crooks DR, Rouault TA. Both human ferredoxins 1 and 2 and ferredoxin reductase are important for iron-sulfur cluster biogenesis. Biochim Biophys Acta. 2012;1823(2):484\u201392. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.11.002.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"3616_CR69","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1021\/acs.biochem.6b00447","volume":"56","author":"K Cai","year":"2017","unstructured":"Cai K, Tonelli M, Frederick RO, Markley JL. Human mitochondrial ferredoxin 1 (FDX1) and ferredoxin 2 (FDX2) both bind cysteine desulfurase and donate electrons for iron-sulfur cluster biosynthesis. Biochemistry. 2017;56(3):487\u201399. https:\/\/doi.org\/10.1021\/acs.biochem.6b00447.","journal-title":"Biochemistry"},{"issue":"7","key":"3616_CR70","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","volume":"15","author":"P Tsvetkov","year":"2019","unstructured":"Tsvetkov P, et al. Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nat Chem Biol. 2019;15(7):681\u20139. https:\/\/doi.org\/10.1038\/s41589-019-0291-9.","journal-title":"Nat Chem Biol"},{"key":"3616_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.923737","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang C, et al. Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker. Front Genet. 2022;13: 923737. https:\/\/doi.org\/10.3389\/fgene.2022.923737.","journal-title":"Front Genet"},{"key":"3616_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.962028","volume":"13","author":"C Xiao","year":"2022","unstructured":"Xiao C, et al. Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer. Front Genet. 2022;13: 962028. https:\/\/doi.org\/10.3389\/fgene.2022.962028.","journal-title":"Front Genet"},{"key":"3616_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.938134","volume":"13","author":"L Yang","year":"2022","unstructured":"Yang L, Zhang Y, Wang Y, Jiang P, Liu F, Feng N. Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: a pan-cancer analysis. Front Pharmacol. 2022;13: 938134. https:\/\/doi.org\/10.3389\/fphar.2022.938134.","journal-title":"Front Pharmacol"},{"issue":"20","key":"3616_CR74","doi-asserted-by":"publisher","first-page":"7522","DOI":"10.1074\/jbc.TM117.000259","volume":"293","author":"A Solmonson","year":"2018","unstructured":"Solmonson A, DeBerardinis RJ. Lipoic acid metabolism and mitochondrial redox regulation. J Biol Chem. 2018;293(20):7522\u201330. https:\/\/doi.org\/10.1074\/jbc.TM117.000259.","journal-title":"J Biol Chem"},{"issue":"7905","key":"3616_CR75","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-04557-9","volume":"604","author":"A Solmonson","year":"2022","unstructured":"Solmonson A, et al. Compartmentalized metabolism supports midgestation mammalian development. Nature. 2022;604(7905):349\u201353. https:\/\/doi.org\/10.1038\/s41586-022-04557-9.","journal-title":"Nature"},{"issue":"1","key":"3616_CR76","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12967-022-03630-1","volume":"20","author":"C Yan","year":"2022","unstructured":"Yan C, Niu Y, Ma L, Tian L, Ma J. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma. J Transl Med. 2022;20(1):452. https:\/\/doi.org\/10.1186\/s12967-022-03630-1.","journal-title":"J Transl Med"},{"key":"3616_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.930041","volume":"13","author":"H Lv","year":"2022","unstructured":"Lv H, et al. Comprehensive analysis of cuproptosis-related genes in immune infiltration and prognosis in melanoma. Front Pharmacol. 2022;13: 930041. https:\/\/doi.org\/10.3389\/fphar.2022.930041.","journal-title":"Front Pharmacol"},{"key":"3616_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.952129","volume":"12","author":"Y Cai","year":"2022","unstructured":"Cai Y, et al. Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers. Front Oncol. 2022;12: 952129. https:\/\/doi.org\/10.3389\/fonc.2022.952129.","journal-title":"Front Oncol"},{"issue":"24","key":"3616_CR79","doi-asserted-by":"publisher","first-page":"16615","DOI":"10.1074\/jbc.R114.563148","volume":"289","author":"MS Patel","year":"2014","unstructured":"Patel MS, Nemeria NS, Furey W, Jordan F. The pyruvate dehydrogenase complexes: structure-based function and regulation. J Biol Chem. 2014;289(24):16615\u201323. https:\/\/doi.org\/10.1074\/jbc.R114.563148.","journal-title":"J Biol Chem"},{"issue":"5","key":"3616_CR80","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1172\/jci110176","volume":"67","author":"KF Sheu","year":"1981","unstructured":"Sheu KF, Hu CW, Utter MF. Pyruvate dehydrogenase complex activity in normal and deficient fibroblasts. J Clin Invest. 1981;67(5):1463\u201371. https:\/\/doi.org\/10.1172\/jci110176.","journal-title":"J Clin Invest"},{"issue":"11","key":"3616_CR81","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.plaphy.2011.07.001","volume":"49","author":"J Casteel","year":"2011","unstructured":"Casteel J, Miernyk JA, Thelen JJ. Mapping the lipoylation site of Arabidopsis thaliana plastidial dihydrolipoamide S-acetyltransferase using mass spectrometry and site-directed mutagenesis. Plant Physiol Biochem. 2011;49(11):1355\u201361. https:\/\/doi.org\/10.1016\/j.plaphy.2011.07.001.","journal-title":"Plant Physiol Biochem"},{"issue":"3","key":"3616_CR82","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s11596-023-2755-0","volume":"43","author":"F Gao","year":"2023","unstructured":"Gao F, Yuan Y, Ding Y, Li PY, Chang Y, He XX. DLAT as a cuproptosis promoter and a molecular target of elesclomol in hepatocellular carcinoma. Curr Med Sci. 2023;43(3):526\u201338. https:\/\/doi.org\/10.1007\/s11596-023-2755-0.","journal-title":"Curr Med Sci"},{"issue":"21","key":"3616_CR83","doi-asserted-by":"publisher","first-page":"R877","DOI":"10.1016\/j.cub.2011.09.040","volume":"21","author":"RA Festa","year":"2011","unstructured":"Festa RA, Thiele DJ. Copper: an essential metal in biology. Curr Biol. 2011;21(21):R877\u201383. https:\/\/doi.org\/10.1016\/j.cub.2011.09.040.","journal-title":"Curr Biol"},{"key":"3616_CR84","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a036863","author":"JH Cha","year":"2020","unstructured":"Cha JH, Chan LC, Song MS, Hung MC. New approaches on cancer immunotherapy. Cold Spring Harb Perspect Med. 2020. https:\/\/doi.org\/10.1101\/cshperspect.a036863.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"11","key":"3616_CR85","first-page":"2442","volume":"9","author":"B Zhou","year":"2019","unstructured":"Zhou B, et al. Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma. Am J Cancer Res. 2019;9(11):2442\u201355.","journal-title":"Am J Cancer Res"},{"key":"3616_CR86","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2023.5343","author":"P Li","year":"2024","unstructured":"Li P, Sun Q, Bai S, Wang H, Zhao L. Combination of the cuproptosis inducer disulfiram and anti-PD-L1 abolishes NSCLC resistance by ATP7B to regulate the HIF-1 signaling pathway. Int J Mol Med. 2024. https:\/\/doi.org\/10.3892\/ijmm.2023.5343.","journal-title":"Int J Mol Med"},{"issue":"20","key":"3616_CR87","doi-asserted-by":"publisher","first-page":"13805","DOI":"10.1021\/jacs.3c14247","volume":"146","author":"Y Huang","year":"2024","unstructured":"Huang Y, et al. Enzyme core spherical nucleic acid that enables enhanced cuproptosis and antitumor immune response through alleviating tumor hypoxia. J Am Chem Soc. 2024;146(20):13805\u201316. https:\/\/doi.org\/10.1021\/jacs.3c14247.","journal-title":"J Am Chem Soc"},{"issue":"1","key":"3616_CR88","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12929-022-00866-3","volume":"29","author":"A Tiwari","year":"2022","unstructured":"Tiwari A, Trivedi R, Lin SY. Tumor microenvironment: barrier or opportunity towards effective cancer therapy. J Biomed Sci. 2022;29(1):83. https:\/\/doi.org\/10.1186\/s12929-022-00866-3.","journal-title":"J Biomed Sci"},{"issue":"1","key":"3616_CR89","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13578-022-00948-7","volume":"12","author":"A Jiang","year":"2022","unstructured":"Jiang A, et al. A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma. Cell Biosci. 2022;12(1):209. https:\/\/doi.org\/10.1186\/s13578-022-00948-7.","journal-title":"Cell Biosci"},{"key":"3616_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122512","volume":"307","author":"X Yu","year":"2024","unstructured":"Yu X, et al. Cuproptotic nanoinducer-driven proteotoxic stress potentiates cancer immunotherapy by activating the mtDNA-cGAS-STING signaling. Biomaterials. 2024;307: 122512. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122512.","journal-title":"Biomaterials"},{"issue":"1","key":"3616_CR91","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40824-023-00389-4","volume":"27","author":"S Shen","year":"2023","unstructured":"Shen S, et al. Copper-induced injectable hydrogel with nitric oxide for enhanced immunotherapy by amplifying immunogenic cell death and regulating cancer associated fibroblasts. Biomater Res. 2023;27(1):44. https:\/\/doi.org\/10.1186\/s40824-023-00389-4.","journal-title":"Biomater Res"},{"key":"3616_CR92","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000207","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, et al. Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery. J Immunother Cancer. 2020. https:\/\/doi.org\/10.1136\/jitc-2019-000207.","journal-title":"J Immunother Cancer"},{"key":"3616_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194715","author":"X Gao","year":"2022","unstructured":"Gao X, et al. Disulfiram\/copper induces immunogenic cell death and enhances CD47 blockade in hepatocellular carcinoma. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14194715.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"3616_CR94","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41418-023-01125-0","volume":"30","author":"C Xiong","year":"2023","unstructured":"Xiong C, Ling H, Hao Q, Zhou X. Cuproptosis: p53-regulated metabolic cell death? Cell Death Differ. 2023;30(4):876\u201384. https:\/\/doi.org\/10.1038\/s41418-023-01125-0.","journal-title":"Cell Death Differ"},{"key":"3616_CR95","doi-asserted-by":"publisher","first-page":"1019153","DOI":"10.3389\/fonc.2022.1019153","volume":"12","author":"F Cheng","year":"2022","unstructured":"Cheng F, et al. Relationship between copper and immunity: the potential role of copper in tumor immunity. Front Oncol. 2022;12:1019153. https:\/\/doi.org\/10.3389\/fonc.2022.1019153.","journal-title":"Front Oncol"},{"issue":"9","key":"3616_CR96","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/iub.2341","volume":"72","author":"Y Li","year":"2020","unstructured":"Li Y. Copper homeostasis: emerging target for cancer treatment. IUBMB Life. 2020;72(9):1900\u20138. https:\/\/doi.org\/10.1002\/iub.2341.","journal-title":"IUBMB Life"},{"key":"3616_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.841814","volume":"9","author":"V Oliveri","year":"2022","unstructured":"Oliveri V. Selective targeting of cancer cells by copper ionophores: an overview. Front Mol Biosci. 2022;9: 841814. https:\/\/doi.org\/10.3389\/fmolb.2022.841814.","journal-title":"Front Mol Biosci"},{"issue":"12","key":"3616_CR98","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1002\/1878-0261.13079","volume":"15","author":"W Gao","year":"2021","unstructured":"Gao W, Huang Z, Duan J, Nice EC, Lin J, Huang C. Elesclomol induces copper-dependent ferroptosis in colorectal cancer cells via degradation of ATP7A. Mol Oncol. 2021;15(12):3527\u201344. https:\/\/doi.org\/10.1002\/1878-0261.13079.","journal-title":"Mol Oncol"},{"issue":"7","key":"3616_CR99","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, et al. Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy. 2023;19(7):1982\u201396. https:\/\/doi.org\/10.1080\/15548627.2023.2165323.","journal-title":"Autophagy"},{"issue":"7","key":"3616_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102139","volume":"298","author":"NM Garza","year":"2022","unstructured":"Garza NM, Zulkifli M, Gohil VM. Elesclomol elevates cellular and mitochondrial iron levels by delivering copper to the iron import machinery. J Biol Chem. 2022;298(7): 102139. https:\/\/doi.org\/10.1016\/j.jbc.2022.102139.","journal-title":"J Biol Chem"},{"issue":"3","key":"3616_CR101","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/bs9.0000000000000117","volume":"4","author":"D Nie","year":"2022","unstructured":"Nie D, Chen C, Li Y, Zeng C. Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis. Blood Sci. 2022;4(3):152\u20134. https:\/\/doi.org\/10.1097\/bs9.0000000000000117.","journal-title":"Blood Sci"},{"issue":"14","key":"3616_CR102","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.7150\/jca.77445","volume":"13","author":"X Nie","year":"2022","unstructured":"Nie X, Chen H, Xiong Y, Chen J, Liu T. Anisomycin has a potential toxicity of promoting cuproptosis in human ovarian cancer stem cells by attenuating YY1\/lipoic acid pathway activation. J Cancer. 2022;13(14):3503\u201314. https:\/\/doi.org\/10.7150\/jca.77445.","journal-title":"J Cancer"},{"key":"3616_CR103","doi-asserted-by":"publisher","first-page":"123025","DOI":"10.1016\/j.ijpharm.2023.123025","volume":"640","author":"J Zhang","year":"2023","unstructured":"Zhang J, et al. Syphilis mimetic nanoparticles for cuproptosis-based synergistic cancer therapy via reprogramming copper metabolism. Int J Pharm. 2023;640:123025. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123025.","journal-title":"Int J Pharm"},{"issue":"22","key":"3616_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202300167","volume":"12","author":"J Zhang","year":"2023","unstructured":"Zhang J, Peng L, Hao Y, Yang H, Zhao W, Mao C. Biodegradable CuMoO(4) nanodots with multienzyme activities for multimodal treatment of tumor. Adv Healthc Mater. 2023;12(22): e2300167. https:\/\/doi.org\/10.1002\/adhm.202300167.","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"3616_CR105","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12672-023-00729-9","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang S, Zong Y, Chen L, Li Q, Li Z, Meng R. The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics. Discov Oncol. 2023;14(1):103. https:\/\/doi.org\/10.1007\/s12672-023-00729-9.","journal-title":"Discov Oncol"},{"issue":"8","key":"3616_CR106","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41416-022-02127-4","volume":"128","author":"X Zhang","year":"2023","unstructured":"Zhang X, et al. AMPK phosphorylates and stabilises copper transporter 1 to synergise metformin and copper chelator for breast cancer therapy. Br J Cancer. 2023;128(8):1452\u201365. https:\/\/doi.org\/10.1038\/s41416-022-02127-4.","journal-title":"Br J Cancer"},{"issue":"1","key":"3616_CR107","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ctrv.2008.07.004","volume":"35","author":"A Gupte","year":"2009","unstructured":"Gupte A, Mumper RJ. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev. 2009;35(1):32\u201346. https:\/\/doi.org\/10.1016\/j.ctrv.2008.07.004.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"3616_CR108","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canlet.2013.05.027","volume":"337","author":"S Wadhwa","year":"2013","unstructured":"Wadhwa S, Mumper RJ. D-penicillamine and other low molecular weight thiols: review of anticancer effects and related mechanisms. Cancer Lett. 2013;337(1):8\u201321. https:\/\/doi.org\/10.1016\/j.canlet.2013.05.027.","journal-title":"Cancer Lett"},{"issue":"19","key":"3616_CR109","doi-asserted-by":"publisher","first-page":"8760","DOI":"10.1039\/c5dt00634a","volume":"44","author":"ME Helsel","year":"2015","unstructured":"Helsel ME, Franz KJ. Pharmacological activity of metal binding agents that alter copper bioavailability. Dalton Trans. 2015;44(19):8760\u201370. https:\/\/doi.org\/10.1039\/c5dt00634a.","journal-title":"Dalton Trans"},{"key":"3616_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031069","author":"S Baldari","year":"2020","unstructured":"Baldari S, Di Rocco G, Toietta G. Current biomedical use of copper chelation therapy. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21031069.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3616_CR111","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/02652030802562938","volume":"26","author":"V Simeone","year":"2009","unstructured":"Simeone V, Baser N, Perrelli D, Cesari G, El Bilali H, Natale P. Residues of rotenone, azadirachtin, pyrethrins and copper used to control Bactrocera oleae (Gmel.) in organic olives and oil. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2009;26(4):475\u201381. https:\/\/doi.org\/10.1080\/02652030802562938.","journal-title":"Food Addit Contam Part A Chem Anal Control Expo Risk Assess"},{"issue":"3","key":"3616_CR112","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1124\/mol.106.024398","volume":"70","author":"E Hinoi","year":"2006","unstructured":"Hinoi E, et al. A molecular mechanism of pyruvate protection against cytotoxicity of reactive oxygen species in osteoblasts. Mol Pharmacol. 2006;70(3):925\u201335. https:\/\/doi.org\/10.1124\/mol.106.024398.","journal-title":"Mol Pharmacol"},{"issue":"6","key":"3616_CR113","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1158\/1535-7163.Mct-11-0864","volume":"11","author":"S Fu","year":"2012","unstructured":"Fu S, Naing A, Fu C, Kuo MT, Kurzrock R. Overcoming platinum resistance through the use of a copper-lowering agent. Mol Cancer Ther. 2012;11(6):1221\u20135. https:\/\/doi.org\/10.1158\/1535-7163.Mct-11-0864.","journal-title":"Mol Cancer Ther"},{"key":"3616_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114643","volume":"192","author":"W Sun","year":"2023","unstructured":"Sun W, et al. Nanosensitizer-mediated unique dynamic therapy tactics for effective inhibition of deep tumors. Adv Drug Deliv Rev. 2023;192: 114643. https:\/\/doi.org\/10.1016\/j.addr.2022.114643.","journal-title":"Adv Drug Deliv Rev"},{"issue":"39","key":"3616_CR115","doi-asserted-by":"publisher","first-page":"44199","DOI":"10.1021\/acsami.2c12990","volume":"14","author":"Z Chen","year":"2022","unstructured":"Chen Z, et al. 2D copper(II) metalated metal-organic framework nanocomplexes for dual-enhanced photodynamic therapy and amplified antitumor immunity. ACS Appl Mater Interfac. 2022;14(39):44199\u2013210. https:\/\/doi.org\/10.1021\/acsami.2c12990.","journal-title":"ACS Appl Mater Interfac"},{"issue":"14","key":"3616_CR116","doi-asserted-by":"publisher","first-page":"6060","DOI":"10.1039\/c3cs35486e","volume":"42","author":"H Wei","year":"2013","unstructured":"Wei H, Wang E. Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes. Chem Soc Rev. 2013;42(14):6060\u201393. https:\/\/doi.org\/10.1039\/c3cs35486e.","journal-title":"Chem Soc Rev"},{"issue":"27","key":"3616_CR117","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201901893","volume":"31","author":"D Wang","year":"2019","unstructured":"Wang D, et al. A mesoporous nanoenzyme derived from metal-organic frameworks with endogenous oxygen generation to alleviate tumor hypoxia for significantly enhanced photodynamic therapy. Adv Mater. 2019;31(27): e1901893. https:\/\/doi.org\/10.1002\/adma.201901893.","journal-title":"Adv Mater"},{"issue":"6","key":"3616_CR118","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1021\/ac404201s","volume":"86","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, et al. Small molecule-initiated light-activated semiconducting polymer dots: an integrated nanoplatform for targeted photodynamic therapy and imaging of cancer cells. Anal Chem. 2014;86(6):3092\u20139. https:\/\/doi.org\/10.1021\/ac404201s.","journal-title":"Anal Chem"},{"issue":"12","key":"3616_CR119","doi-asserted-by":"publisher","first-page":"20164","DOI":"10.1021\/acsnano.1c08108","volume":"15","author":"X Liang","year":"2021","unstructured":"Liang X, Chen M, Bhattarai P, Hameed S, Tang Y, Dai Z. Complementing cancer photodynamic therapy with ferroptosis through iron oxide loaded porphyrin-grafted lipid nanoparticles. ACS Nano. 2021;15(12):20164\u201380. https:\/\/doi.org\/10.1021\/acsnano.1c08108.","journal-title":"ACS Nano"},{"issue":"17","key":"3616_CR120","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202000899","volume":"9","author":"C Liu","year":"2020","unstructured":"Liu C, et al. A pH-sensitive self-assembled and carrier-free nanoparticle based on charge reversal for enhanced synergetic chemo-phototherapy. Adv Healthc Mater. 2020;9(17): e2000899. https:\/\/doi.org\/10.1002\/adhm.202000899.","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"3616_CR121","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1039\/d1bm01876k","volume":"10","author":"N Yang","year":"2022","unstructured":"Yang N, et al. A carrier free photodynamic oxidizer for enhanced tumor therapy by redox homeostasis disruption. Biomater Sci. 2022;10(6):1575\u201381. https:\/\/doi.org\/10.1039\/d1bm01876k.","journal-title":"Biomater Sci"},{"issue":"1","key":"3616_CR122","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1021\/cr400135x","volume":"114","author":"C Santini","year":"2014","unstructured":"Santini C, Pellei M, Gandin V, Porchia M, Tisato F, Marzano C. Advances in copper complexes as anticancer agents. Chem Rev. 2014;114(1):815\u201362. https:\/\/doi.org\/10.1021\/cr400135x.","journal-title":"Chem Rev"},{"issue":"25","key":"3616_CR123","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.2174\/092986710791859315","volume":"17","author":"F Wang","year":"2010","unstructured":"Wang F, Jiao P, Qi M, Frezza M, Dou QP, Yan B. Turning tumor-promoting copper into an anti-cancer weapon via high-throughput chemistry. Curr Med Chem. 2010;17(25):2685\u201398. https:\/\/doi.org\/10.2174\/092986710791859315.","journal-title":"Curr Med Chem"},{"issue":"7684","key":"3616_CR124","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature25016","volume":"552","author":"Z Skrott","year":"2017","unstructured":"Skrott Z, et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature. 2017;552(7684):194\u20139. https:\/\/doi.org\/10.1038\/nature25016.","journal-title":"Nature"},{"issue":"7","key":"3616_CR125","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1073\/pnas.89.7.3070","volume":"89","author":"AK Godwin","year":"1992","unstructured":"Godwin AK, Meister A, O\u2019Dwyer PJ, Huang CS, Hamilton TC, Anderson ME. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci U S A. 1992;89(7):3070\u20134. https:\/\/doi.org\/10.1073\/pnas.89.7.3070.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3616_CR126","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.phrs.2016.01.001","volume":"106","author":"L Amable","year":"2016","unstructured":"Amable L. Cisplatin resistance and opportunities for precision medicine. Pharmacol Res. 2016;106:27\u201336. https:\/\/doi.org\/10.1016\/j.phrs.2016.01.001.","journal-title":"Pharmacol Res"},{"issue":"33","key":"3616_CR127","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.1039\/d2tb01150f","volume":"10","author":"Y Lu","year":"2022","unstructured":"Lu Y, Pan Q, Gao W, Pu Y, He B. Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine via cuproptosis. J Mater Chem B. 2022;10(33):6296\u2013306. https:\/\/doi.org\/10.1039\/d2tb01150f.","journal-title":"J Mater Chem B"},{"issue":"12","key":"3616_CR128","doi-asserted-by":"publisher","first-page":"e202213922","DOI":"10.1002\/anie.202213922","volume":"62","author":"J Zhou","year":"2023","unstructured":"Zhou J, et al. Photothermally triggered copper payload release for cuproptosis-promoted cancer synergistic therapy. Angew Chem Int Ed Engl. 2023;62(12):e202213922. https:\/\/doi.org\/10.1002\/anie.202213922.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"8","key":"3616_CR129","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202308241","volume":"36","author":"L Qiao","year":"2024","unstructured":"Qiao L, et al. Self-destructive copper carriers induce pyroptosis and cuproptosis for efficient tumor immunotherapy against dormant and recurrent tumors. Adv Mater. 2024;36(8): e2308241. https:\/\/doi.org\/10.1002\/adma.202308241.","journal-title":"Adv Mater"},{"issue":"2","key":"3616_CR130","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1021\/jacs.8b08714","volume":"141","author":"B Ma","year":"2019","unstructured":"Ma B, et al. Self-assembled copper-amino acid nanoparticles for in situ glutathione \u201cAND\u201d H(2)O(2) sequentially triggered chemodynamic therapy. J Am Chem Soc. 2019;141(2):849\u201357. https:\/\/doi.org\/10.1021\/jacs.8b08714.","journal-title":"J Am Chem Soc"},{"issue":"4","key":"3616_CR131","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.bbrc.2009.08.085","volume":"388","author":"M Gilleron","year":"2009","unstructured":"Gilleron M, Marechal X, Montaigne D, Franczak J, Neviere R, Lancel S. NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis. Biochem Biophys Res Commun. 2009;388(4):727\u201331. https:\/\/doi.org\/10.1016\/j.bbrc.2009.08.085.","journal-title":"Biochem Biophys Res Commun"},{"key":"3616_CR132","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9420539","volume":"2017","author":"M Skonieczna","year":"2017","unstructured":"Skonieczna M, Hejmo T, Poterala-Hejmo A, Cieslar-Pobuda A, Buldak RJ. NADPH oxidases: insights into selected functions and mechanisms of action in cancer and stem cells. Oxid Med Cell Longev. 2017;2017: 9420539. https:\/\/doi.org\/10.1155\/2017\/9420539.","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"3616_CR133","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1073\/pnas.1417047112","volume":"112","author":"EL Samuel","year":"2015","unstructured":"Samuel EL, et al. Highly efficient conversion of superoxide to oxygen using hydrophilic carbon clusters. Proc Natl Acad Sci USA. 2015;112(8):2343\u20138. https:\/\/doi.org\/10.1073\/pnas.1417047112.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3616_CR134","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.canlet.2008.02.044","volume":"266","author":"M Ushio-Fukai","year":"2008","unstructured":"Ushio-Fukai M, Nakamura Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett. 2008;266(1):37\u201352. https:\/\/doi.org\/10.1016\/j.canlet.2008.02.044.","journal-title":"Cancer Lett"},{"issue":"4","key":"3616_CR135","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.drudis.2018.02.001","volume":"23","author":"RJ Bose","year":"2018","unstructured":"Bose RJ, Paulmurugan R, Moon J, Lee SH, Park H. Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics. Drug Discov Today. 2018;23(4):891\u20139. https:\/\/doi.org\/10.1016\/j.drudis.2018.02.001.","journal-title":"Drug Discov Today"},{"key":"3616_CR136","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.biomaterials.2018.08.004","volume":"182","author":"J Yang","year":"2018","unstructured":"Yang J, et al. Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance. Biomaterials. 2018;182:145\u201356. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.08.004.","journal-title":"Biomaterials"},{"issue":"8","key":"3616_CR137","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1039\/d0tb02476g","volume":"9","author":"X Meng","year":"2021","unstructured":"Meng X, Zhang X, Lei Y, Cao D, Wang Z. Biodegradable copper-metformin nanoscale coordination polymers for enhanced chemo\/chemodynamic synergistic therapy by reducing oxygen consumption to promote H(2)O(2) accumulation. J Mater Chem B. 2021;9(8):1988\u20132000. https:\/\/doi.org\/10.1039\/d0tb02476g.","journal-title":"J Mater Chem B"},{"key":"3616_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2022.102686","volume":"305","author":"JE Cun","year":"2022","unstructured":"Cun JE, et al. Copper-based metal-organic frameworks for biomedical applications. Adv Colloid Interface Sci. 2022;305: 102686. https:\/\/doi.org\/10.1016\/j.cis.2022.102686.","journal-title":"Adv Colloid Interface Sci"},{"key":"3616_CR139","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.actbio.2022.10.048","volume":"155","author":"Q Wang","year":"2023","unstructured":"Wang Q, et al. Amorphous NiB@IrO(x) nanozymes trigger efficient apoptosis-ferroptosis hybrid therapy. Acta Biomater. 2023;155:575\u201387. https:\/\/doi.org\/10.1016\/j.actbio.2022.10.048.","journal-title":"Acta Biomater"},{"issue":"21","key":"3616_CR140","doi-asserted-by":"publisher","first-page":"21134","DOI":"10.1021\/acsnano.3c04903","volume":"17","author":"J Xia","year":"2023","unstructured":"Xia J, et al. Copper-loaded nanoheterojunction enables superb orthotopic osteosarcoma therapy via oxidative stress and cell cuproptosis. ACS Nano. 2023;17(21):21134\u201352. https:\/\/doi.org\/10.1021\/acsnano.3c04903.","journal-title":"ACS Nano"},{"issue":"11","key":"3616_CR141","doi-asserted-by":"publisher","first-page":"10206","DOI":"10.1021\/acsnano.3c00326","volume":"17","author":"S Ning","year":"2023","unstructured":"Ning S, et al. Type-I AIE photosensitizer loaded biomimetic system boosting cuproptosis to inhibit breast cancer metastasis and rechallenge. ACS Nano. 2023;17(11):10206\u201317. https:\/\/doi.org\/10.1021\/acsnano.3c00326.","journal-title":"ACS Nano"},{"issue":"4","key":"3616_CR142","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202302537","volume":"13","author":"Y Ruan","year":"2024","unstructured":"Ruan Y, et al. Engineered microbial nanohybrids for tumor-mediated NIR II photothermal enhanced ferroptosis\/cuproptosis and immunotherapy. Adv Healthc Mater. 2024;13(4): e2302537. https:\/\/doi.org\/10.1002\/adhm.202302537.","journal-title":"Adv Healthc Mater"},{"issue":"12","key":"3616_CR143","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41565-019-0589-5","volume":"14","author":"W Song","year":"2019","unstructured":"Song W, Anselmo AC, Huang L. Nanotechnology intervention of the microbiome for cancer therapy. Nat Nanotechnol. 2019;14(12):1093\u2013103. https:\/\/doi.org\/10.1038\/s41565-019-0589-5.","journal-title":"Nat Nanotechnol"},{"issue":"11","key":"3616_CR144","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nrc2934","volume":"10","author":"NS Forbes","year":"2010","unstructured":"Forbes NS. Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer. 2010;10(11):785\u201394. https:\/\/doi.org\/10.1038\/nrc2934.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"3616_CR145","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/anie.201510031","volume":"55","author":"C Zhang","year":"2016","unstructured":"Zhang C, et al. Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized fenton reaction. Angew Chem Int Ed Engl. 2016;55(6):2101\u20136. https:\/\/doi.org\/10.1002\/anie.201510031.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"18","key":"3616_CR146","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1002\/anie.201712027","volume":"57","author":"LS Lin","year":"2018","unstructured":"Lin LS, et al. Simultaneous fenton-like ion delivery and glutathione depletion by MnO(2) -based nanoagent to enhance chemodynamic therapy. Angew Chem Int Ed Engl. 2018;57(18):4902\u20136. https:\/\/doi.org\/10.1002\/anie.201712027.","journal-title":"Angew Chem Int Ed Engl"},{"key":"3616_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120278","volume":"258","author":"K Zhang","year":"2020","unstructured":"Zhang K, Meng X, Yang Z, Dong H, Zhang X. Enhanced cancer therapy by hypoxia-responsive copper metal-organic frameworks nanosystem. Biomaterials. 2020;258: 120278. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120278.","journal-title":"Biomaterials"},{"issue":"6","key":"3616_CR148","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202113619","volume":"61","author":"C Yao","year":"2022","unstructured":"Yao C, et al. A DNA nanocomplex containing cascade DNAzymes and promoter-like zn-mn-ferrite for combined gene\/chemo-dynamic therapy. Angew Chem Int Ed Engl. 2022;61(6): e202113619. https:\/\/doi.org\/10.1002\/anie.202113619.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"36","key":"3616_CR149","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202207770","volume":"61","author":"Y Dong","year":"2022","unstructured":"Dong Y, et al. Lysosome interference enabled by proton-driven dynamic assembly of DNA nanoframeworks inside cells. Angew Chem Int Ed Engl. 2022;61(36): e202207770. https:\/\/doi.org\/10.1002\/anie.202207770.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"48","key":"3616_CR150","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202204502","volume":"61","author":"S Cai","year":"2022","unstructured":"Cai S, et al. Tumor-microenvironment-responsive cascade reactions by a cobalt-single-atom nanozyme for synergistic nanocatalytic chemotherapy. Angew Chem Int Ed Engl. 2022;61(48): e202204502. https:\/\/doi.org\/10.1002\/anie.202204502.","journal-title":"Angew Chem Int Ed Engl"},{"key":"3616_CR151","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.biomaterials.2019.03.014","volume":"206","author":"R Hu","year":"2019","unstructured":"Hu R, et al. Ultrasmall Cu(2\u2013x)S nanodots as photothermal-enhanced Fenton nanocatalysts for synergistic tumor therapy at NIR-II biowindow. Biomaterials. 2019;206:101\u201314. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.03.014.","journal-title":"Biomaterials"},{"key":"3616_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121502","volume":"284","author":"K Zhang","year":"2022","unstructured":"Zhang K, et al. Disruption of dual homeostasis by a metal-organic framework nanoreactor for ferroptosis-based immunotherapy of tumor. Biomaterials. 2022;284: 121502. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121502.","journal-title":"Biomaterials"},{"key":"3616_CR153","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jcis.2023.03.065","volume":"641","author":"Z Yang","year":"2023","unstructured":"Yang Z, Zhao Z, Cheng H, Shen Y, Xie A, Zhu M. In-situ fabrication of novel Au nanoclusters-Cu(2+)@sodium alginate\/hyaluronic acid nanohybrid gels for cuproptosis enhanced photothermal\/photodynamic\/chemodynamic therapy via tumor microenvironment regulation. J Colloid Interface Sci. 2023;641:215\u201328. https:\/\/doi.org\/10.1016\/j.jcis.2023.03.065.","journal-title":"J Colloid Interface Sci"},{"issue":"12","key":"3616_CR154","doi-asserted-by":"publisher","first-page":"7609","DOI":"10.1021\/acs.nanolett.8b03178","volume":"18","author":"L Zhang","year":"2018","unstructured":"Zhang L, Wan SS, Li CX, Xu L, Cheng H, Zhang XZ. An adenosine triphosphate-responsive autocatalytic Fenton nanoparticle for tumor ablation with self-supplied H(2)O(2) and acceleration of Fe(III)\/Fe(II) conversion. Nano Lett. 2018;18(12):7609\u201318. https:\/\/doi.org\/10.1021\/acs.nanolett.8b03178.","journal-title":"Nano Lett"},{"issue":"4","key":"3616_CR155","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1021\/acs.chemrev.0c00977","volume":"121","author":"Z Tang","year":"2021","unstructured":"Tang Z, Zhao P, Wang H, Liu Y, Bu W. Biomedicine meets Fenton chemistry. Chem Rev. 2021;121(4):1981\u20132019. https:\/\/doi.org\/10.1021\/acs.chemrev.0c00977.","journal-title":"Chem Rev"},{"issue":"1","key":"3616_CR156","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1021\/jacs.2c09139","volume":"145","author":"S Liu","year":"2023","unstructured":"Liu S, et al. Iron-containing protein-mimic supramolecular iron delivery systems for ferroptosis tumor therapy. J Am Chem Soc. 2023;145(1):160\u201370. https:\/\/doi.org\/10.1021\/jacs.2c09139.","journal-title":"J Am Chem Soc"},{"issue":"48","key":"3616_CR157","doi-asserted-by":"publisher","first-page":"25328","DOI":"10.1002\/anie.202106750","volume":"60","author":"J Liu","year":"2021","unstructured":"Liu J, et al. A titanium nitride nanozyme for pH-responsive and irradiation-enhanced cascade-catalytic tumor therapy. Angew Chem Int Ed Engl. 2021;60(48):25328\u201338. https:\/\/doi.org\/10.1002\/anie.202106750.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"5","key":"3616_CR158","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202206592","volume":"19","author":"Q Yu","year":"2023","unstructured":"Yu Q, et al. A cascade nanoreactor of metal-protein-polyphenol capsule for oxygen-mediated synergistic tumor starvation and chemodynamic therapy. Small. 2023;19(5): e2206592. https:\/\/doi.org\/10.1002\/smll.202206592.","journal-title":"Small"},{"issue":"38","key":"3616_CR159","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202204291","volume":"61","author":"Z Wang","year":"2022","unstructured":"Wang Z, Yang J, Qin G, Zhao C, Ren J, Qu X. An intelligent nanomachine guided by DNAzyme logic system for precise chemodynamic therapy. Angew Chem Int Ed Engl. 2022;61(38): e202204291. https:\/\/doi.org\/10.1002\/anie.202204291.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"50","key":"3616_CR160","doi-asserted-by":"publisher","first-page":"22537","DOI":"10.1002\/anie.202003653","volume":"59","author":"Y Li","year":"2020","unstructured":"Li Y, et al. Redox dyshomeostasis strategy for hypoxic tumor therapy based on DNAzyme-loaded electrophilic ZIFs. Angew Chem Int Ed Engl. 2020;59(50):22537\u201343. https:\/\/doi.org\/10.1002\/anie.202003653.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"11","key":"3616_CR161","doi-asserted-by":"publisher","first-page":"e202217448","DOI":"10.1002\/anie.202217448","volume":"62","author":"L Wang","year":"2023","unstructured":"Wang L, et al. A molybdenum disulfide nanozyme with charge-enhanced activity for ultrasound-mediated cascade-catalytic tumor ferroptosis. Angew Chem Int Ed Engl. 2023;62(11):e202217448. https:\/\/doi.org\/10.1002\/anie.202217448.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"12","key":"3616_CR162","doi-asserted-by":"publisher","first-page":"6300","DOI":"10.1002\/anie.202015979","volume":"60","author":"D Yi","year":"2021","unstructured":"Yi D, Zhao J, Li L. An enzyme-activatable engineered DNAzyme sensor for cell-selective imaging of metal ions. Angew Chem Int Ed Engl. 2021;60(12):6300\u20134. https:\/\/doi.org\/10.1002\/anie.202015979.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"28","key":"3616_CR163","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202301429","volume":"12","author":"Q Yu","year":"2023","unstructured":"Yu Q, et al. DNAzyme-mediated cascade nanoreactor for cuproptosis-promoted pancreatic cancer synergistic therapy. Adv Healthc Mater. 2023;12(28): e2301429. https:\/\/doi.org\/10.1002\/adhm.202301429.","journal-title":"Adv Healthc Mater"},{"key":"3616_CR164","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.actbio.2023.04.003","volume":"164","author":"C Ni","year":"2023","unstructured":"Ni C, et al. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy. Acta Biomater. 2023;164:474\u201386. https:\/\/doi.org\/10.1016\/j.actbio.2023.04.003.","journal-title":"Acta Biomater"},{"issue":"17","key":"3616_CR165","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1039\/c7cs00891k","volume":"47","author":"LH Fu","year":"2018","unstructured":"Fu LH, Qi C, Lin J, Huang P. Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment. Chem Soc Rev. 2018;47(17):6454\u201372. https:\/\/doi.org\/10.1039\/c7cs00891k.","journal-title":"Chem Soc Rev"},{"issue":"1","key":"3616_CR166","doi-asserted-by":"publisher","first-page":"5044","DOI":"10.1038\/s41467-018-07197-8","volume":"9","author":"Z Yu","year":"2018","unstructured":"Yu Z, Zhou P, Pan W, Li N, Tang B. A biomimetic nanoreactor for synergistic chemiexcited photodynamic therapy and starvation therapy against tumor metastasis. Nat Commun. 2018;9(1):5044. https:\/\/doi.org\/10.1038\/s41467-018-07197-8.","journal-title":"Nat Commun"},{"key":"3616_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120869","volume":"274","author":"F Shao","year":"2021","unstructured":"Shao F, Wu Y, Tian Z, Liu S. Biomimetic nanoreactor for targeted cancer starvation therapy and cascade amplificated chemotherapy. Biomaterials. 2021;274: 120869. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120869.","journal-title":"Biomaterials"},{"key":"3616_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120987","volume":"275","author":"X Zhang","year":"2021","unstructured":"Zhang X, et al. Cyclic reactions-mediated self-supply of H(2)O(2) and O(2) for cooperative chemodynamic\/starvation cancer therapy. Biomaterials. 2021;275: 120987. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120987.","journal-title":"Biomaterials"},{"issue":"5","key":"3616_CR169","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/anie.201610682","volume":"56","author":"W Fan","year":"2017","unstructured":"Fan W, et al. Glucose-responsive sequential generation of hydrogen peroxide and nitric oxide for synergistic cancer starving-like\/gas therapy. Angew Chem Int Ed Engl. 2017;56(5):1229\u201333. https:\/\/doi.org\/10.1002\/anie.201610682.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"3\u20134","key":"3616_CR170","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10555-012-9384-6","volume":"31","author":"S Biswas","year":"2012","unstructured":"Biswas S, Lunec J, Bartlett K. Non-glucose metabolism in cancer cells\u2013is it all in the fat? Cancer Metastasis Rev. 2012;31(3\u20134):689\u201398. https:\/\/doi.org\/10.1007\/s10555-012-9384-6.","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"3616_CR171","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"PP Hsu","year":"2008","unstructured":"Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134(5):703\u20137. https:\/\/doi.org\/10.1016\/j.cell.2008.08.021.","journal-title":"Cell"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03616-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03616-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03616-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T15:02:41Z","timestamp":1753714961000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03616-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":171,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3616"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03616-3","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"544"}}